Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Prepaid Assets (2016 - 2026)

Ocular Therapeutix has reported Prepaid Assets over the past 14 years, most recently at $11.2 million for Q1 2026.

  • For Q1 2026, Prepaid Assets rose 17.74% year-over-year to $11.2 million; the TTM value through Mar 2026 reached $11.2 million, up 17.74%, while the annual FY2025 figure was $10.9 million, 19.34% down from the prior year.
  • Prepaid Assets for Q1 2026 was $11.2 million at Ocular Therapeutix, up from $10.9 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $13.5 million in Q4 2024 and troughed at $3.3 million in Q3 2022.
  • A 5-year average of $7.4 million and a median of $7.7 million in 2024 define the central range for Prepaid Assets.
  • Biggest five-year swings in Prepaid Assets: soared 170.49% in 2024 and later crashed 39.53% in 2025.
  • Year by year, Prepaid Assets stood at $4.0 million in 2022, then soared by 93.5% to $7.8 million in 2023, then soared by 72.66% to $13.5 million in 2024, then dropped by 19.34% to $10.9 million in 2025, then rose by 3.29% to $11.2 million in 2026.
  • Business Quant data shows Prepaid Assets for OCUL at $11.2 million in Q1 2026, $10.9 million in Q4 2025, and $8.0 million in Q3 2025.